8-K: Wellgistics Health Engages Draper, Inc. for Investor Relations and Achieves SOC 2 Type 1 Compliance

Wellgistics Health enters a consulting agreement with Draper, Inc. for investor relations and business development services, and announces successful completion of a third-party audit for SOC 2 Type 1 compliance.

Summary

• Wellgistics Health, Inc. has entered into a consulting agreement with Draper, Inc. effective March 17, 2025.
• Draper will provide investor relations and business development services to Wellgistics Health.
• The initial term of the Consulting Agreement is three months, with automatic one-month renewals until terminated.
• Either party can terminate the agreement with seven days' written notice.
• Wellgistics Health will pay Draper 100,000 restricted shares of common stock upon execution of the agreement and an additional 100,000 shares for each subsequent term.
• Wellgistics Health also announced on March 18, 2025, that it has achieved SOC 2 Type 1 compliance following a third-party audit.
• This compliance validates that Wellgistics Health meets industry standards for security, availability, processing integrity, confidentiality, and privacy.
• The audit was conducted by Sensiba LLP.

Sentiment

Score: 7

Explanation: The news is moderately positive due to the consulting agreement and SOC 2 compliance, but the issuance of restricted shares introduces a slight negative aspect.

Positives

• The engagement of Draper, Inc. could enhance Wellgistics Health's investor relations and business development efforts.
• Achieving SOC 2 Type 1 compliance demonstrates a commitment to data security and regulatory compliance, potentially attracting more clients and partners.
• The SOC 2 Type 1 compliance strengthens Wellgistics Health's position as a trusted partner for pharmacies, providers, and health systems.

Negatives

• The issuance of 100,000 restricted shares to Draper for consulting services dilutes existing shareholders' equity.
• The consulting agreement's terms, including automatic renewal and share-based compensation, could create ongoing financial obligations.

Risks

• The success of the consulting agreement with Draper depends on Draper's ability to deliver effective investor relations and business development services.
• Failure to maintain SOC 2 Type 1 compliance could negatively impact Wellgistics Health's reputation and ability to attract and retain clients.
• Forward-looking statements in the press release are subject to risks and uncertainties that could cause actual results to differ materially.

Future Outlook

The press release contains forward-looking statements regarding the Company's projects, potential financial performance, and growth opportunities, but cautions that these statements are subject to risks and uncertainties.

Management Comments

• Srini Kalla, CIO at Wellgistics Health, stated that achieving SOC 2 Type 1 compliance demonstrates the company's commitment to protecting customer data and maintaining a strong foundation for future growth.

Industry Context

The SOC 2 Type 1 compliance is particularly relevant in the healthcare technology industry, where data security and privacy are critical concerns. This achievement positions Wellgistics Health favorably compared to competitors who may not have achieved the same level of compliance.

Comparison to Industry Standards

• SOC 2 Type 1 compliance is a widely recognized industry standard for data security, similar to HIPAA compliance in the healthcare sector.
• Companies like Veeva Systems and Cerner Corporation also prioritize SOC 2 compliance to ensure data protection for their healthcare clients.
• Achieving SOC 2 Type 1 compliance demonstrates Wellgistics Health's commitment to meeting industry benchmarks for security and reliability.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of restricted shares.
• Customers and partners may gain confidence in Wellgistics Health's data security practices due to SOC 2 Type 1 compliance.
• Employees may benefit from the company's enhanced reputation and potential growth opportunities.

Next Steps

• Draper, Inc. will begin providing investor relations and business development services to Wellgistics Health.
• Wellgistics Health will continue to operate in compliance with SOC 2 Type 1 standards.
• Wellgistics Health will continue to monitor and address risks and uncertainties related to forward-looking statements.

Key Dates

Keywords

SOC 2 Type 1, compliance, Draper, Inc., investor relations, consulting agreement, Wellgistics Health, business development, healthcare technology, pharmacy solutions